NeuroBo Pharmaceuticals Inc.
15 clinical trials · Sponsor
◉ Watch NeuroBo Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| First in Human Study in Subjects With Obesity, But Otherwise Healthy (NCT06252220) | NeuroBo Pharmaceuticals Inc. | 2024-03-25 |
| Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH (NCT06054815) | NeuroBo Pharmaceuticals Inc. | 2023-09-14 |
| Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients (NCT04603924) | NeuroBo Pharmaceuticals Inc. | 2020-10-07 |
Track NeuroBo Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.